Study links canine and human mortality biomarkers

A new Dog Aging Project study reports that blood-based metabolic signals tied to mortality in people are also strongly aligned in dogs, adding evidence that the two species share core features of aging biology. In the paper, published in The Journals of Gerontology: Series A, researchers analyzed plasma metabolomics data from 937 dogs in the project’s Precision Cohort and found 23 metabolites significantly associated with all-cause mortality. When they compared those findings with five independent human studies, the direction of risk matched 64% of the time, a highly significant overlap. The work comes from the Dog Aging Project, a long-running collaboration led by researchers at Texas A&M, the University of Washington, and other partners. (academic.oup.com)

Why it matters: For veterinary professionals, the study strengthens the case for companion dogs as a practical translational model for aging research, not just because dogs develop many of the same chronic conditions as people, but because they age on a shorter timeline while living in human environments and receiving sophisticated medical care. The Dog Aging Project now includes more than 50,000 U.S. dogs, and its Precision Cohort is generating longitudinal biospecimen data that could eventually support earlier risk stratification, biomarker discovery, and intervention studies in canine patients. Texas A&M and NIH-backed collaborators are already extending that work through TRIAD, a rapamycin trial designed to test whether aging biology can be modified in dogs. (academic.oup.com)

What to watch: As more longitudinal follow-up accrues, researchers say the next step is to identify additional biomarkers across other “omics” layers and test whether they can predict specific age-related diseases, not just all-cause mortality. (academic.oup.com)